Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy
Zeni et al.
Ann Rheum Dis 2008;67:1055-1056.
FULL TEXT
Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
Hairston et al.
Arch Dermatol 2006;142:1413-1418.
ABSTRACT
| FULL TEXT
Treatment of Livedoid Vasculopathy With Low-Molecular-Weight Heparin: Report of 2 Cases
Hairston et al.
Arch Dermatol 2003;139:987-990.
FULL TEXT
Livedo Vasculopathy vs Small Vessel Cutaneous Vasculitis: Cytokine and Platelet P-Selectin Studies
Papi et al.
Arch Dermatol 1998;134:447-452.
ABSTRACT
| FULL TEXT
Livedoid Vasculopathy: What Is It?
Jorizzo
Arch Dermatol 1998;134:491-493.
FULL TEXT
Livedoid Vasculitis: Response to Low-Dose Danazol
Hsiao and Chiu
Arch Dermatol 1996;132:749-751.
ABSTRACT
Livedo Vasculitis: Therapy With Pentoxifylline
Sams
Arch Dermatol 1988;124:684-687.
ABSTRACT
Livedoid Vasculitis and Central Nervous System Involvement in Systemic Lupus Erythematosus
Yasue
Arch Dermatol 1986;122:66-70.
ABSTRACT
Vascular Ulcers in Scleroderma
Thomas and Winkelmann
Arch Dermatol 1983;119:803-807.
ABSTRACT
Cutaneous Periarteritis Nodosa: Immunofluorescence Studies
Diaz-Perez et al.
Arch Dermatol 1980;116:56-58.
ABSTRACT
Cutaneous and Subcutaneous Endarteritis Obliterans
Kossard et al.
Arch Dermatol 1978;114:1652-1658.
ABSTRACT